Diligence memo · auto-generated · as of July 3, 2026

Iremedy Healthcare Companies, Inc.

Iremedy Healthcare Companies, Inc. looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 1.9× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Iremedy Healthcare Companies, Inc. operates in Hospitals and Physicians, based in STUART.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Iremedy Healthcare Companies, Inc. has raised $5.6M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $3.6M on 2016-12-05.

Most recent recorded round closed around 2024-07-31.

Valuation (modeled)modeled

Provath models Iremedy Healthcare Companies, Inc. at approximately $8.6M (range $1.8M–$22M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.77× the median modeled value of Seed Hospitals and Physicians companies in 2022–2024 (23 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 46 months.

Last raise 23 mo ago; this sector typically re-raises about every 12 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.9× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 74% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 30% of those peers.

Closest niche peers: Maplemere Ventures LLC, San Joaquin Valley Surgery Center, LLC, Specialty Surgical Center of Encino LLC, RemoteMD International, Inc., Great Seal Surgery Center, LLC.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.